HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

OWLT

Owlet, Inc. (NYSE)

Healthcare — Medical Devices

Owlet, Inc. provides digital parenting solutions in the United States, the United Kingdom, and internationally. The company offers a digital parenting platform that provides real-time data and insights to parents. It also provides sock monitors, including Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology that tracks vital signs, such as pulse rate, activity, oxygen level, and sleep patterns; BabySat, which is intended for infants with conditions, including respiratory syncytial virus, pneumonia, bronchitis, croup, and other diagnoses; and Dream Sight, an audio and video monitor that enables parents to monitor their child. In addition, the company offers Dream Duo, which integrates Dream Sock and Dream Sight to create a connected health and safety system; Owlet360, a subscription service that provides personalized understanding of the babies' development, health, and sleep trends; and accessories, such as fabric accessory socks and the Owlet Sock Travel Case. The company was founded in 2012 and is headquartered in Lehi, Utah.

Strong Buy 1.0 / 5 4 analysts
$6.16
+$0.42 (+7.32%)
Target: $13.00 (111.0%)
Sign in to add OWLT to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$179.03M
P/E Ratio (TTM)-
Forward P/E56.00
EPS (TTM)$-2.57
Dividend Yield-
Profit Margin-43.00%
Revenue Growth6.40%
ROE-526.19%
Debt/Equity55.44
Recommendation Strong Buy 1.0
Analyst Target$13.00
Analysts4
Indexes NYSE

Technical Indicators

RSI (14)81.0
Beta1.86
SMA 20-
SMA 40-
52-Week High$16.94
52-Week Low$4.19
50-Day Avg$5.29
200-Day Avg$9.02
Avg Volume238.0K
Volume205.3K

Performance Analysis

NEUTRAL

OWLT presents a mixed picture with both positive and negative indicators.

~ Trading at 15% of its 52-week range.
- RSI at 81.0 indicates overbought conditions — a pullback may be due.
~ Modest revenue growth of 6.4% year-over-year.
- Operating at a loss with -43.0% margin.
+ Wall Street consensus is "Strong Buy" from 4 analysts.
+ Average analyst target of $13.00 implies 111.0% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:25 UTC

Back to Screener Export Report